Do COVID antibodies protect against the Delta variant? A large-scale study shows that they do. Researchers found that reinfection is far less common among recovered patients than Pfizer-vaccinated individuals.
Reports say people who received both doses of the Pfizer-Biontech vaccine are six times more likely to contract the Delta variant. They are also seven times more likely to develop symptoms than patients who already gained acquired immunity from infection.
In other words, people who previously had COVID-19 are less likely to acquire the Delta variant, develop the symptoms, and require hospitalizations.
…Shouldn’t Discourage Them From Getting The Vaccines
While the study results are great news for those who have already recovered from COVID-19, it doesn’t mean they shouldn’t get the vaccines when it’s their turn.
After all, another study pointed out that the best-protected group is individuals who had a previous COVID-19 infection and are fully vaccinated.
Besides, the chance of reinfection considers various factors, like your immune system, overall health, genetics, the variant you were exposed to, and how you were exposed.
Comments
Share your thoughts
Be the first to let Hello Doctor know your thoughts!
Join Us or Log In to join the discussion